Clarity Medical Group Holding Ltd. said it has appointed Grant Thornton Advisory Services Ltd. as forensic adviser to a separate special committee to conduct an independent forensic investigation into allegations of material misstatements in the company’s prospectus, as required under resumption guidance issued by the Hong Kong Stock Exchange. The company’s shares have been suspended from trading since April 15, 2025, and will remain suspended pending further notice.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clarity Medical Group Holding Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260305-12043177), on March 05, 2026, and is solely responsible for the information contained therein.
Comments